Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 5,298,187	$ 7,301,955
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash and Investments held in Trust Account	(97,361)	(10,645)
Offering costs allocated to warrants	0	862,470
Excess of Private Placement Warrants fair value over purchase price	0	1,242,401
Change in fair value of warrant liability	(6,449,317)	(9,488,914)
Changes in current assets and liabilities:
Prepaid assets	28,782	(779,700)
Accrued costs and expenses	499,902	70,630
Due to related party	488,899	2,000
Net cash used in operating activities	(230,908)	(799,803)
Cash Flows from Investing Activities:
Investment held in Trust Account		(287,500,000)
Net cash used in investing activities		(287,500,000)
Cash flows from financing activities:
Proceeds from initial public offering, net of underwriters' discount	287,500,000	281,750,000
Proceeds from issuance of Private Placement Warrants	15,052,227	7,750,000
Proceeds of Promissory Note - Related Party		200,000
Payment of Promissory Note - Related Party		(200,000)
Payments of offering costs	(15,610,840)	(547,330)
Net cash provided by financing activities		288,952,670
Net change in cash	(230,908)	652,867
Cash, beginning of the period	381,400	0
Cash, end of the period	$ 150,492	652,867
Supplemental disclosure of cash flow information:
Initial classification of warrant liability		22,802,227
Initial classification of Class A ordinary shares subject to possible redemption		287,500,000
Deferred underwriting commissions charged to additional paid in capital		10,062,500
Offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares		25,000
Deferred Offering Costs Included In Accrued Expenses		$ 251,751